DK2914748T3 - Forudsigelse af udviklingen af toxicitet af farmaceutika for mennesker, under anvendelse af humane stamcellelignende celler og metaboliske forholdstal - Google Patents
Forudsigelse af udviklingen af toxicitet af farmaceutika for mennesker, under anvendelse af humane stamcellelignende celler og metaboliske forholdstal Download PDFInfo
- Publication number
- DK2914748T3 DK2914748T3 DK13850210.9T DK13850210T DK2914748T3 DK 2914748 T3 DK2914748 T3 DK 2914748T3 DK 13850210 T DK13850210 T DK 13850210T DK 2914748 T3 DK2914748 T3 DK 2914748T3
- Authority
- DK
- Denmark
- Prior art keywords
- human
- predicting
- evolution
- toxicity
- cells
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
- G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/22—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material
- G01N23/225—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material using electron or ion
- G01N23/2255—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material using electron or ion using incident ion beams, e.g. proton beams
- G01N23/2258—Measuring secondary ion emission, e.g. secondary ion mass spectrometry [SIMS]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Developmental Biology & Embryology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261721746P | 2012-11-02 | 2012-11-02 | |
| US201361827407P | 2013-05-24 | 2013-05-24 | |
| PCT/US2013/067980 WO2014071137A1 (en) | 2012-11-02 | 2013-11-01 | Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2914748T3 true DK2914748T3 (da) | 2019-06-11 |
Family
ID=50628081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13850210.9T DK2914748T3 (da) | 2012-11-02 | 2013-11-01 | Forudsigelse af udviklingen af toxicitet af farmaceutika for mennesker, under anvendelse af humane stamcellelignende celler og metaboliske forholdstal |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20150301025A1 (https=) |
| EP (1) | EP2914748B1 (https=) |
| JP (2) | JP6339581B2 (https=) |
| CN (1) | CN104822843B (https=) |
| CA (1) | CA2888064C (https=) |
| DK (1) | DK2914748T3 (https=) |
| HU (1) | HUE043604T2 (https=) |
| MX (1) | MX362991B (https=) |
| WO (1) | WO2014071137A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10060932B2 (en) * | 2013-07-09 | 2018-08-28 | Stemina Biomarker Discovery, Inc. | Biomarkers of autism spectrum disorder |
| FI126398B (en) | 2014-12-18 | 2016-11-15 | Upm Kymmene Corp | Method for chemical testing |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| CN109207551B (zh) * | 2017-07-07 | 2023-05-26 | 上海睿智化学研究有限公司 | 一种筛选叶酸代谢相关药物的方法 |
| WO2019173671A1 (en) * | 2018-03-09 | 2019-09-12 | Stemina Biomarker Discovery, Inc. | In vitro assay to predict cardiotoxicity |
| US12548652B2 (en) | 2020-11-30 | 2026-02-10 | Sanofi | Classifying images of dose-response graphs |
| CN119667130B (zh) * | 2025-02-13 | 2025-05-09 | 生态环境部华南环境科学研究所(生态环境部生态环境应急研究所) | 一种基于血清组氨酸/犬尿氨酸快速评估双酚类物质暴露毒性效应的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| US20060258672A1 (en) * | 2005-05-13 | 2006-11-16 | Joseph Barbosa | Multicyclic compounds and methods of their use |
| JP5421767B2 (ja) * | 2006-04-10 | 2014-02-19 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | ヒト胚性幹細胞を使用して薬学的化合物および他の化学物質の毒性を評価するための試薬および方法 |
| JP5814337B2 (ja) * | 2010-03-22 | 2015-11-17 | ステミナ バイオマーカー ディスカバリー， インコーポレイテッド | ヒト幹細胞様細胞及びメタボロミクスを使用した医薬のヒト発生毒性の予測 |
| US20120071543A1 (en) * | 2010-05-14 | 2012-03-22 | Carter Jacob L | Formulations of diluted genetic material and methods for making same |
| US9447506B2 (en) | 2012-07-30 | 2016-09-20 | David Whitmore | Cathodic protection of a concrete structure |
-
2013
- 2013-11-01 HU HUE13850210A patent/HUE043604T2/hu unknown
- 2013-11-01 US US14/439,723 patent/US20150301025A1/en not_active Abandoned
- 2013-11-01 MX MX2015005476A patent/MX362991B/es unknown
- 2013-11-01 JP JP2015540802A patent/JP6339581B2/ja active Active
- 2013-11-01 CA CA2888064A patent/CA2888064C/en active Active
- 2013-11-01 CN CN201380057328.0A patent/CN104822843B/zh active Active
- 2013-11-01 WO PCT/US2013/067980 patent/WO2014071137A1/en not_active Ceased
- 2013-11-01 DK DK13850210.9T patent/DK2914748T3/da active
- 2013-11-01 EP EP13850210.9A patent/EP2914748B1/en active Active
-
2017
- 2017-12-20 US US15/848,188 patent/US10209240B2/en active Active
-
2018
- 2018-05-10 JP JP2018091559A patent/JP6581244B2/ja active Active
- 2018-12-18 US US16/224,150 patent/US20190128872A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN104822843A (zh) | 2015-08-05 |
| US20180128814A1 (en) | 2018-05-10 |
| EP2914748B1 (en) | 2019-03-13 |
| MX2015005476A (es) | 2015-10-29 |
| JP6581244B2 (ja) | 2019-09-25 |
| JP6339581B2 (ja) | 2018-06-06 |
| US10209240B2 (en) | 2019-02-19 |
| US20150301025A1 (en) | 2015-10-22 |
| CA2888064A1 (en) | 2014-05-08 |
| WO2014071137A1 (en) | 2014-05-08 |
| US20190128872A1 (en) | 2019-05-02 |
| EP2914748A1 (en) | 2015-09-09 |
| MX362991B (es) | 2019-03-01 |
| JP2016501516A (ja) | 2016-01-21 |
| CN104822843B (zh) | 2020-01-21 |
| EP2914748A4 (en) | 2016-06-01 |
| CA2888064C (en) | 2023-05-30 |
| HUE043604T2 (hu) | 2019-08-28 |
| JP2018157823A (ja) | 2018-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286327A (en) | Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue | |
| DK3260140T3 (da) | Fremgangsmåder og produkter til transficering af celler | |
| IL250824A0 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
| DK2855736T3 (da) | Elektrolysator og energisystem | |
| DK2994528T3 (da) | Organoider, der omfatter isolerede renale celler og anvendelser deraf | |
| PL2606120T4 (pl) | Ludzkie komórki ułatwiające tolerancję i ich zastosowanie | |
| DK2914748T3 (da) | Forudsigelse af udviklingen af toxicitet af farmaceutika for mennesker, under anvendelse af humane stamcellelignende celler og metaboliske forholdstal | |
| EP2770899A4 (en) | TISSUE AND CELLULAR IMAGING | |
| BR112014026022A2 (pt) | conjuntos de montagem, rastreadores solares e métodos relacionados | |
| DK2555807T5 (da) | Skabelon-øceller og små øcelleklynger til behandling af diabetes | |
| BR112013000994A2 (pt) | implante expansível | |
| DK3257943T3 (da) | Fremgangsmåder og vektorer til celleimmortalisering | |
| DK2817406T3 (da) | Engangsseparator til tilbageholdelse og tilbageføring af celler | |
| PL2661798T3 (pl) | Sposób komunikacji, komunikacyjny system i zawierający go system magazynowania energii | |
| DK2956183T3 (da) | Faste substrater til fremme af celle og væv vækst | |
| CL2012003085A1 (es) | Metodo de injerto de celulas de tejidos solidos | |
| DOS2012000119S (es) | Acumulador y/o bateria | |
| EP2879794A4 (en) | CELL CULTURE | |
| DK2858196T3 (da) | System, fremgangsmåde og program til energibesparelse | |
| HUE050820T2 (hu) | Moduláris energiatároló eljárás és rendszer | |
| IL225785A0 (en) | Heterocyclic compounds, compositions comprising the same and uses thereof | |
| PT2804475T (pt) | Criopreservação de células, tecidos e órgãos | |
| DK3297063T3 (da) | Kompositmembran og lithium-ion-batteri dermed | |
| BR112013009579A2 (pt) | método e comprimido | |
| BR112013013858A2 (pt) | sistema de simulação de nergia de bateria |